| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -45,022 | -52,922 | -18,257 | -66,414 |
| Depreciation and amortization | 14,990 | 14,744 | 11,726 | 8,758 |
| Stock-based compensation expense | 28,116 | 18,205 | 15,727 | 17,933 |
| (gain) loss on disposal of assets | 409 | -257 | -853 | -1,490 |
| Loss on extinguishment of long-term debt | NaN | -5,926 | 0 | 0 |
| Amortization of debt issuance costs and discount | 133 | 589 | 860 | 860 |
| Noncash lease expense | 2,797 | 2,313 | 2,410 | 2,046 |
| Change in the fair value of contingent consideration | 187 | -10,624 | 0 | 0 |
| Accretion of marketable securities purchased at a discount | 458 | 646 | 500 | 538 |
| Deferred income taxes | 1,155 | 2,382 | -34,503 | 2,039 |
| Accounts receivable, net | 35,662 | -20,109 | -5,875 | 22,343 |
| Contract assets | 13,434 | 10,312 | -1,415 | -9,028 |
| Inventories | 24,571 | 14,318 | 14,054 | 5,205 |
| Prepaids and other current assets | -4,081 | -1,995 | -582 | 8,420 |
| Other non-current assets | 26,098 | -5,702 | 1,747 | -10,308 |
| Trade payables | -8,161 | 11,854 | -12,783 | 1,370 |
| Accrued expenses | 10,825 | -4,602 | -1,353 | 6,736 |
| Employee benefits payables | 1,309 | -41,894 | 40,128 | 3,542 |
| Contract liabilities | 45,753 | -12,419 | -16,404 | 16,511 |
| Other current liabilities | -2,941 | 2,207 | -1,456 | 3,797 |
| Non-current lease liabilities | -2,993 | -3,238 | -1,722 | -4,877 |
| Other non-current liabilities | 71 | 161 | -320 | 137 |
| Net cash used in operating activities | -50,332 | -64,531 | -23,523 | -23,242 |
| Purchases of property, equipment and software | 27,065 | 49,654 | 45,912 | 32,042 |
| Proceeds on disposal of assets | 715 | 0 | 253 | 128 |
| Cash paid for business combinations, net of acquired cash | 8,021 | 0 | 132,441 | NaN |
| Purchases of marketable securities | 91,328 | 87,539 | 59,455 | 43,686 |
| Maturities of marketable securities | 89,979 | 33,046 | 30,327 | 64,796 |
| Sale of marketable securities | NaN | -6,766 | 0 | 3,383 |
| Net cash used in investing activities | -35,720 | -104,147 | -207,228 | -7,421 |
| Proceeds from atm equity offerings | 450,347 | 280,604 | 468,806 | 303,841 |
| Issuance costs related to atm equity offerings | 4,740 | 6,380 | 10,638 | 7,408 |
| Proceeds from the exercise of stock options | 1,081 | 33 | 2,160 | 331 |
| Proceeds from employee stock purchase plan | 4,189 | 3,296 | 2,915 | 2,599 |
| Proceeds from sale of employees restricted stock units to cover taxes | 52,337 | 32,687 | 39,944 | 23,405 |
| Minimum tax withholding paid on behalf of employees for restricted stock units | 39,848 | 47,815 | 25,251 | 23,844 |
| Purchase of capped calls related to issuance of convertible senior notes | NaN | 0 | 0 | 0 |
| Proceeds from issuance of convertible senior notes | NaN | 0 | 0 | 0 |
| Proceeds from secured term loans | 0 | 0 | 1,716 | 0 |
| Repayments on secured term loan | 0 | 72,817 | 3,895 | 8,314 |
| Payment of contingent consideration | NaN | 0 | NaN | NaN |
| Payment of debt issuance costs | 0 | 0 | 0 | 0 |
| Finance lease principal payments | 73 | 71 | 71 | 65 |
| Net cash provided by financing activities | 463,293 | 189,537 | 475,686 | 290,545 |
| Effect of exchange rate changes on cash and cash equivalents | 237 | -24 | -1,213 | 855 |
| Net increase in cash and cash equivalents and restricted cash | 377,478 | 20,835 | 243,722 | 260,737 |
| Cash and cash equivalents, and restricted cash, beginning of period | 833,545 | 812,710 | 568,988 | 308,251 |
| Cash and cash equivalents, and restricted cash, end of period | 1,211,023 | 833,545 | 812,710 | 568,988 |
Rocket Lab Corp (RKLB)
Rocket Lab Corp (RKLB)